Indications for Sentinel Lymph Node Biopsy in the Setting of Prophylactic Mastectomy

Journal of the American College of Surgeons

Volumn 209, Issue 6, 2009, Pages 746-752

  Laronga, Christine ^a   Lee, M Catherine ^a   McGuire, Kandace P ^b   Meade, Tammi ^a   Carter, W Bradford ^a   Hoover, Susan ^c   Cox, Charles E ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c The Breast Clinic of Memphis

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AXILLA; BREAST CANCER; CANCER INVASION; CANCER RISK; DATA BASE; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; INCIDENCE; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MASTECTOMY; METASTASIS; NIPPLE; OCCULT CANCER; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY;

BREAST NEOPLASMS; FEMALE; HUMANS; MASTECTOMY; MIDDLE AGED; SENTINEL LYMPH NODE BIOPSY;

EID: 70649095171     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2009.08.010     Document Type: Article

References (22)

1. McLaughlin S.A., Stempel M., Morris E.A., et al. Can magnetic resonance imaging be used to select patients for sentinel lymph node biopsy in prophylactic mastectomy?. Cancer 112 (2008) 1214-1221
2. Boughey J.C., Khakpour N., Meric-Bernstam F., et al. Selective use of sentinel lymph node surgery during prophylactic mastectomy. Cancer 107 (2006) 1440-1447
3. Swenson K.K., Nissen M.J., Ceronsky C., et al. Comparison of side effects between sentinel lymph node and axillary lymph node dissection for breast cancer. Ann Surg Oncol 9 (2002) 745-753
4. Rutstein L.A., Johnson R.R., Poller W.R., et al. Predictors of residual invasive disease after core needle biopsy diagnosis of ductal carcinoma in situ. Breast J 13 (2007) 251-257
5. Huo L., Sneige N., Hunt K.K., et al. Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ. Cancer 107 (2006) 1760-1768
6. Sakr R., Antoine M., Barranger E., et al. Value of sentinel lymph node biopsy in breast ductal carcinoma in situ upstaged to invasive carcinoma. Breast J 14 (2008) 55-60
7. Goyal A., Douglas-Jones A., Monypenny I., et al. Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: analysis of 587 cases. Breast Cancer Res Treat 98 (2006) 311-314
8. Langer I., Guller U., Berclaz G., et al. Morbidity if sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study of 659 patients. Ann Surg 245 (2007) 452-461
9. Mansel R.E., Fallowfield L., Kissin M., et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 98 (2006) 599-609
10. McLaughlin S.A., Wright M.J., Morris K.T., et al. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol 26 (2008) 5213-5219
11. Yi M., Meric-Bernstam F., Middleton L.P., et al. Predictors of contralateral breast cancer in patients with unilateral breast cancer undergoing contralateral prophylactic mastectomy. Cancer 115 (2009) 962-971
12. Graves K., Peshkin B., Halbert C., et al. Predictors and outcomes of contralateral prophylactic mastectomy among breast cancer survivors. Breast Cancer Res Treat 104 (2007) 321-329
13. Frost M.H., Slezak J.M., Tran N.V., et al. Satisfaction after contralateral prophylactic mastectomy: the significance of mastectomy type, reconstructive complications, and body appearance. J Clin Oncol 23 (2005) 7849-7856
14. Lostumbo L., Carbine N., Wallace J., and Ezzo J. Prophylactic mastectomy for the prevention of breast cancer. Cochrane Database Syst Rev (2004) CD002748
15. Herrinton L.J., Barlow W.E., Yu O., et al. Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project. J Clin Oncol 23 (2005) 4275-4286
16. McDonnell S.K., Schaid D., Myers J.L., et al. Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer. J Clin Oncol 19 (2001) 3938-3943
17. Babiera G., Rao R., Feng L., et al. Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor. Ann Surg Oncol 13 (2006) 776-782
18. Quan G., Pommier S.J., and Pommier R.F. Incidence and outcomes of contralateral breast cancers. Am J Surg 195 (2008) 645-650
19. Schrag D., Kuntz K.M., Garber J.E., and Weeks J.C. Life expectancy gains from cancer prevention strategies for women with breast cancer and BRCA1 or BRCA2 mutations. JAMA 283 (2000) 617-624
20. Soran A., Falk J., Bonaventura M., et al. Is routine sentinel lymph node biopsy indicated in women undergoing contralateral prophylactic mastectomy?. Magee-Womens Hospital Experience. Ann Surg Oncol 14 (2007) 646-651
21. Dupont E.L., Kuhn M.A., McCann C., et al. The role of sentinel lymph node biopsy in women undergoing prophylactic mastectomy. Am J Surg 180 (2000) 274-277
22. Tuttle T.M., Habermann E.B., Grund E.H., et al. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol 25 (2007) 5203-5209